Journal of Health Science Research

Open Access Open Access  Restricted Access Subscription Access

Predictors of Cost of Follow-up Care among Patients with Hypertension and Diabetes Mellitus Attending a Teaching Hospital, North Central, Nigeria


Affiliations
1 Department of Epidemiology and Community Health, UITH/University of Ilorin, Nigeria
2 Department of Medicine, UITH/University of Ilorin, Nigeria
3 Department of Community Medicine, Federal Teaching Hospital Ido-Ekiti/ABUAD, Ado-Ekiti, Nigeria
4 Department of Chemical Pathology, UITH/University of Ilorin, Nigeria
5 Department of Family Medicine, UITH, Ilorin, Nigeria
 

Background: In sub-Saharan Africa, hypertension and diabetes mellitus (type II) remain major causes of cardiovascular disease. The prevalence of hypertension and diabetes remain high in Nigeria while the initial and follow-up management are almost entirely hospital-based. This constitutes huge financial burden not only to the patients, care givers and families, but also to the health system and the government. Information on basic cost of care of hypertension and diabetes and of those having both diseases as co-morbidities is still scanty in Nigeria. There is need to study the factors that strongly determine cost of follow-up care among this group of patients. Methodology: This study is a hospital-based cross-sectional study of 1,203 hypertensive and diabetic patients attending general and medical outpatient clinics of a teaching hospital in Nigeria. Results: The patients spend N6,401 ($32.16) on the average whenever they attend follow-up clinic. Close to threequarter (71.3%) of the patients spent more than 30 minutes to access follow-up clinic while similar proportion (74.3%) spent more than an hour waiting to be seen at the clinics. Major predictors of cost of follow-up care among hypertensive and Diabetics were; Drug, transportation and laboratory costs. Other predictors were; Male gender, long waiting time, accompanies persons; and co-morbidity of hypertension and diabetes. Conclusion: This study recommended that strategies that will reduce the cost of drugs, laboratory tests, and reducing waiting time will reduce the cost of managing hypertension and diabetes in Nigeria.

Keywords

Care, Costs, Diabetes, Follow-up, Hypertension, Predictors.
User
Notifications
Font Size

  • Gaziano TA. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart. 2008; 94(2):140–4. https://doi.org/10.1136/hrt.2007.128785 PMid:18195120

  • Amira CO, Okubadejo NU. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiarycare setting. J Hum Hypertens. 2006; 20(11):894–7. https://doi.org/10.1038/sj.jhh.1002080 PMid:16915299

  • Ekere AU, Yellowe BE, Umune S. Mortality patterns in the accident and emergency department of an urban hospital in Nigeria. Nigerian J Clin Practice. 2005; 8(1):14–8. PMid:16392450

  • Bella AF, Baiyewu O, Bamigboye A, Adeyemi JD, Ikuesan BA, Jegede RO. The pattern of medical illness in a community of elderly Nigerians. Cent Afr J Med. 1993; 39(6):112–6. PMid:8131198

  • Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton P K, He J. Global burden of hypertension: analysis of worldwide data. The lancet. 2005; 365(9455):217–23. http://dx.doi.org/10.1016/S0140-6736(05)17741-1

  • Kirigia JM, Sambo HB, Sambo LG, Barry SP. Economic burden of diabetes mellitus in the WHO African region. BMC International Health and Human Rights. 2009; 9(1):1. https://doi.org/10.1186/1472-698X-9-6 PMid:19405948 PMCid:PMC2691726

  • WHO. Adherence to long term therapies:Evidence for action. Geneva; 2003. Available from: http://apps.who.int/ iris/bitstream/10665/42682/1/9241545992.pdf

  • Smith R. Why a macroeconomic perspective is critical to the prevention of non-communicable disease. Science. 2012; 337(6101):1501–3. https://doi.org/10.1126/science.1222569 PMid:22997330

  • Stewart S, Sliwa K. Preventing CVD in resource-poor areas: perspectives from the ‘real-world’. Nature reviewsCardiology. 2009; 6(7):489–92. https://doi.org/10.1038/ nrcardio.2009.79 PMid:19554008

  • Steven VV., Hilda A, Samuel O, Ademola O, Charles A, Isabella A, et al. Status report on hypertension in AfricaConsultative review for the 6th session of the African Union Conference of Ministers of Health on NCD’s. Pan African Medical Journal. 2013; 16:38. available from: http://www.panafrican-med-journal.com/content/article/16/38/full

  • World Bank. Data. Available from: http://www.worldbank.org/en/country/nigeria

  • Onoka CA, Onwujekwe OE, Hanson K, Uzochukwu BS. Examining catastrophic health expenditures at variable thresholds using household consumption expenditure diaries. Tropical Medicine and International

  • Health. 2011; 16(10):1334–41. https://doi.org/10.111 1/j.1365-3156.2011.02836

  • Zheng B, Poulose A, Holbrook A A. Pilot study on costrelated medication non adherence in Ontario. Journal of Population Therapeutics and Clinical Pharmacology. 2012; 19:239–47.

  • Enwere OO, Salako BL, Falade CO. Prescription and cost consideration at a diabetic clinic in Ibadan, Nigeria: A report. Annals of Ibadan Postgraduate Med. 2006; 4:35–9.

  • Ogbera A. Ekpebegh C. Diabetes mellitus in Nigeria: The past, present and future. World Journal of Diabetes. 2014; 5(6):905–11. https://doi.org/10.4239/wjd.v5.i6.905

  • Osibogun A, Okwor TJ. Anti-hypertensive prescription and cost patterns in an outpatient department of a teaching hospital in Lagos State Nigeria. Open Journal of Preventive Medicine. 2014; 4:156–63. https://doi.org/10.4236/ojpm.2014.44021

  • Ilesanmi OS, Ige OK, Adebiyi AO. The managed hypertensive: The cost of blood pressure control in a Nigerian Town. The Pan African Medical Journal. 2012; 12:96. PMid:23133696 PMCid:PMC3489397

  • Hendriks ME, Bolarinwa OA, Nelissen HE, Boers AC, Gomez GB, Tan CSS, et al. Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria. Journal of Hypertension. 2015; 33(2):376–84. https://doi.org/10.1097/HJH.0000000000000402 PMid:25380164

  • Okechukwu E, Ugwu SC. The laws and administration of retirement in Nigeria: A historical Approach. Kuwait Chapter of Arabian Journal of Business and Management Review. 2011; 1(2):1–10

  • Adebisi OO, Samali A. Poverty and hypertension in Nigerian adults: A barrier to its control and treatment: A review. Unique Research Journal of Medicine and Medical Science. 2013; 1(3):14–20.

  • Ganiyu A, Suleiman IA. Economic burden of drug therapy in hypertension management in a private teaching hospital in Nigeria. British Journal of Pharmaceutical Research. 2014; 4(1):70–8. https://doi.org/10.9734/BJPR/2014/3983

  • Wojuade CA, Fadare SO. Accessibility of health facilities to residents in Ibadan, Nigeria. Research on Humanities and Social Sciences. 2014; A(6):9–14. Available from: http://iiste.org/Journals/index.php/RHSS/article/view-File/11881/12245


Abstract Views: 274

PDF Views: 81




  • Predictors of Cost of Follow-up Care among Patients with Hypertension and Diabetes Mellitus Attending a Teaching Hospital, North Central, Nigeria

Abstract Views: 274  |  PDF Views: 81

Authors

O. A. Bolarinwa
Department of Epidemiology and Community Health, UITH/University of Ilorin, Nigeria
A. Abdulahi
Department of Epidemiology and Community Health, UITH/University of Ilorin, Nigeria
E. O. Sanya
Department of Medicine, UITH/University of Ilorin, Nigeria
P. M. Kolo
Department of Medicine, UITH/University of Ilorin, Nigeria
H. A. Ameen
Department of Epidemiology and Community Health, UITH/University of Ilorin, Nigeria
K. A. Durowade
Department of Community Medicine, Federal Teaching Hospital Ido-Ekiti/ABUAD, Ado-Ekiti, Nigeria
M. M. B. Uthman
Department of Epidemiology and Community Health, UITH/University of Ilorin, Nigeria
J. A. Ogunmodede
Department of Medicine, UITH/University of Ilorin, Nigeria
S. A. Buliaminu
Department of Chemical Pathology, UITH/University of Ilorin, Nigeria
L. O. Odeigah
Department of Family Medicine, UITH, Ilorin, Nigeria
T. M. Akande
Department of Epidemiology and Community Health, UITH/University of Ilorin, Nigeria

Abstract


Background: In sub-Saharan Africa, hypertension and diabetes mellitus (type II) remain major causes of cardiovascular disease. The prevalence of hypertension and diabetes remain high in Nigeria while the initial and follow-up management are almost entirely hospital-based. This constitutes huge financial burden not only to the patients, care givers and families, but also to the health system and the government. Information on basic cost of care of hypertension and diabetes and of those having both diseases as co-morbidities is still scanty in Nigeria. There is need to study the factors that strongly determine cost of follow-up care among this group of patients. Methodology: This study is a hospital-based cross-sectional study of 1,203 hypertensive and diabetic patients attending general and medical outpatient clinics of a teaching hospital in Nigeria. Results: The patients spend N6,401 ($32.16) on the average whenever they attend follow-up clinic. Close to threequarter (71.3%) of the patients spent more than 30 minutes to access follow-up clinic while similar proportion (74.3%) spent more than an hour waiting to be seen at the clinics. Major predictors of cost of follow-up care among hypertensive and Diabetics were; Drug, transportation and laboratory costs. Other predictors were; Male gender, long waiting time, accompanies persons; and co-morbidity of hypertension and diabetes. Conclusion: This study recommended that strategies that will reduce the cost of drugs, laboratory tests, and reducing waiting time will reduce the cost of managing hypertension and diabetes in Nigeria.

Keywords


Care, Costs, Diabetes, Follow-up, Hypertension, Predictors.

References





DOI: https://doi.org/10.18311/jhsr%2F2018%2F21335